Lansoprazole Capsule, Delayed Release
Product Images NDC 83324-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 83324-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chain Drug Marketing Association, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label (Cdma Lanso Caps 14ct Bottle Label)

Packaging label for Lansoprazole delayed-release capsules USP, 15 mg, an acid reducer by Chain Drug Marketing Association. The label states a 24-hour effect and contains 14 capsules, intended for a 14-day course of treatment. Directions for use and other information, including dosing instructions and storage conditions, are presented on the label.*

FDA Label Image

Carton (Cdma Lanso Caps 14ct Carton Label)

Packaging label for Lansoprazole delayed-release capsules USP 15 mg by Chain Drug Marketing Association. The box contains 14 capsules for a 14-day treatment course, marketed as an acid reducer for frequent heartburn. Label features drug facts, directions, warnings, inactive ingredients, and quality certification markings. Includes a color image of one capsule and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.